On-Demand Webinars

1. Selection And Encapsulation Of Capsules For Dry Powder Inhalation

   Dry powder capsules offer a compact, portable means for patients to receive treatment. Examine the challenges of dry powder formulation and unlock the potential of high-dose inhaled medications.

2. HPAPI Drug Product Development And Manufacturing Using Micronization Technology

   Learn how to classify HPAPIs in early development and recommendations for safe product handling, from clinical manufacturing to commercialization.

3. Taste Masking 101: Applications And Technologies 9/28/2021

   Learn about key product parameters affecting patient acceptability and therapy adherence and taste masking strategies, including organoleptic and barrier coating approaches and microencapsulation technologies.

4. Developing And Manufacturing Minitablets To Extend Drug Lifecycle 1/27/2025

   Pharmaceutical companies should leverage oral minitablets to extend drug lifecycles, optimize dosing, and improve patient-centric solutions while overcoming manufacturing challenges.

5. Achieving Desired Particle Size And Yield Through Efficient Micronization 1/22/2025

   In this webinar, experts examine how the right combination of advanced technology and specialized expertise can leverage micronization to address the challenges often faced by small molecule drugs.

6. Accelerating Nasal Dosage Form Development From Early-Phase To Clinical Trial Manufacture 10/21/2024

   Led by Dr. Richard Johnson, Chief Scientific Officer, this 40-minute session covers the five key stages of the UpperNose development platform, highlighting the significance of target product selection and its influence on formulation and clinical outcomes.

7. Regulatory, Cost Implications Of Switching Injectable Delivery Formats

   Launching a large molecule in one format and then switching the delivery format often transpires as a lifecycle management strategy for cost efficiency, supply chain continuity, and patient benefit. 

8. How Drug Delivery Is Enabling A Clinical Trial For Glioblastoma

   Discover highly promising in-vivo data, enabled by a nanoformed drug product for the treatment of glioblastoma multiforme (GBM).

9. Patient- And Planet-Centric Bioavailability And Sustained Delivery

   By reducing the size of drug particles, nanoforming offers new opportunities — from increased bioavailability to sustained drug delivery. Discover the potential benefits supported by case studies.

10. Selecting Container Closure Systems With Confidence: Lyophilization 3/7/2024

    Experts take you through the entire selection process for primary packaging components for lyophilization and provide aspects to consider for all relevant attributes.